Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patients

BACKGROUND: Anti-programmed cell death protein 1 (PD-1) monotherapy is one of the standard systemic therapies for advanced melanoma; however, the efficacy of salvage systemic therapies after PD-1 monotherapy failure (PD-1 MF), particularly in acral melanoma (AM), the main clinical melanoma type in J...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Tatsuhiko, Namikawa, Kenjiro, Yamazaki, Naoya, Kiniwa, Yukiko, Yamasaki, Osamu, Yoshikawa, Shusuke, Inozume, Takashi, Kato, Hiroshi, Nakai, Yasuo, Fukushima, Satoshi, Takenouchi, Tatsuya, Maekawa, Takeo, Matsushita, Shigeto, Otsuka, Atsushi, Nomura, Motoo, Baba, Natsuki, Isei, Taiki, Saito, Shintaro, Fujimoto, Noriki, Tanaka, Ryo, Kaneko, Takahide, Kuwatsuka, Yutaka, Matsuya, Taisuke, Nagase, Kotaro, Onishi, Masazumi, Onuma, Takehiro, Nakamura, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448186/
https://www.ncbi.nlm.nih.gov/pubmed/37636577
http://dx.doi.org/10.3389/fmed.2023.1229937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448186/
https://www.ncbi.nlm.nih.gov/pubmed/37636577
http://dx.doi.org/10.3389/fmed.2023.1229937

Ejemplares similares